UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Section 13a-16 or 15d-16 of the Securities Exchange Act of 1934
For the Month of: December 2016
Commission File Number: 001-37847
MOTIF BIO PLC
(Exact name of Registrant as specified in its charter)
125 Park Avenue
25th Floor, Suite 2622
New York, New York 10011
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o
On December 22, 2016, Motif Bio plc (the “Company”) issued a press release announcing that all resolutions put to shareholders at the Company’s General Meeting were duly passed, a copy of which is attached as Exhibit 99.1 to this Report on Form 6-K. On December 22, 2016, the Company also issued a press release announcing the conversion of certain convertible promissory notes, a copy of which is attached as Exhibit 99.2 to this Report on Form 6-K.
The information in this Report on Form 6-K, including Exhibits 99.1 and 99.2, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Exhibits
Exhibit |
| Exhibit Table |
|
|
|
99.1 |
| Press Release issued by Motif Bio plc, dated December 22, 2016, announcing the results of the Company’s General Meeting. |
|
|
|
99.2 |
| Press Release issued by Motif Bio plc, dated December 22, 2016, announcing the conversion of Convertible Promissory Notes, PDMR Dealing and Total Voting Rights. |
